Business Context and Reporting Period
This Form 8-K Current Report was filed by Gossamer Bio, Inc. on September 6, 2023. The filing addresses a corporate governance event involving the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
On September 6, 2023, Kristina Burow resigned from the Board of Directors. The resignation was attributed to her other board commitments and was not the result of any disagreement with the Company regarding operations, policies, or practices. Consequently, the Board size was reduced from six to five directors, and the number of Class III directors decreased from two to one.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies were disclosed in this report other than the standard disclosure regarding the nature of the director's departure.
Investor Verification Checklist
- Verify the updated composition of the Board of Directors following the reduction to five members.
- Confirm the status of Class III director representation on the Board.
- Review subsequent filings for any impact on corporate governance or strategic direction resulting from this departure.